Multiple Sclerosis Trial, By Invitation NCT07462338 Sponsor: Sanko University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT07462338
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Multiple Sclerosis (MS).
  • People who are 18 years of age or older.
  • People whose MS has a low to moderate level of disability, meaning they are able to walk without using any assistive devices.
  • People who are willing to give their informed consent to participate.
  • People who are able to complete a walking and movement test called the Timed Up and Go (TUG) test.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with severe difficulties in thinking or understanding that would prevent them from following instructions.
  • People who have had an MS relapse (a flare-up of symptoms) within the last 30 days.
  • People who use walking aids in a way that would interfere with completing the Timed Up and Go (TUG) test.
  • People who have other conditions affecting the nervous system, muscles, or bones that impact their walking or balance.
  • People who have any condition that the trial investigator considers would make participation unsafe (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Sanko University
Registry
ClinicalTrials.gov
Start date
15 February 2026
Est. completion
15 March 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Sit-to-Stand and Walk Test (SKYT); Dual-task SKYT tests; The 25-step walk test (S25AYT); Dual-task questionnaire; Mini-BESTest

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov